Prosecution Insights
Last updated: August 15, 2026

The University of Liverpool

7 pending office actions • 7 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Portfolio Summary

7
Total Pending OAs
4
Non-Final OAs
3
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

0
Overdue
0
Due this week
2
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Due ≤ 30 days (2)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (57%)
2
Medium (29%)
1
Easy (14%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only1 (14%)
§103 only2 (29%)
§112 only1 (14%)
Multi-statute (no §101)3 (43%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

7
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

70 h
Manual time on pending OAs
14 h
Time saved (low, 20%)
24 h
Time saved (mid, 35%)
0.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DAVIS, BRIAN J 1 84.8% -4.1%
SHOMER, ISAAC 1 63.3% +30.3%
RAO, PADMAJA S 1 68.5% +37.0%
GRASER, JENNIFER E 1 76.5% +23.6%
CHUNG, HOSUNG CHARLES 1 59.5% +37.2%
SWITZER, JULIET CAROLINE 1 42.4% +53.8%
DEL SOLE, JOSEPH STEVEN 1 32.8% +12.8%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18703186 Solid Compositions Comprising Tenofovir Alafenamide and/or Bictegravir DAVIS, BRIAN J

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18111996 DETECTION OF BACTERIAL INFECTIONS SWITZER, JULIET CAROLINE 26d
18272697 AZAQUINAZOLINE DERIVATIVES FOR USE IN TREATING OR PREVENTING DIROFILARIA INFECTION IN A MAMMAL RAO, PADMAJA S 28d
16608065 POLYMERS DEL SOLE, JOSEPH STEVEN 56d
18270947 NOVEL COMPOSITION GRASER, JENNIFER E

Interview Candidates (6)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.

App #TitleExaminerDue in
18111996 DETECTION OF BACTERIAL INFECTIONS SWITZER, JULIET CAROLINE 26d
18272697 AZAQUINAZOLINE DERIVATIVES FOR USE IN TREATING OR PREVENTING DIROFILARIA INFECTION IN A MAMMAL RAO, PADMAJA S 28d
16608065 POLYMERS DEL SOLE, JOSEPH STEVEN 56d
18696258 Injectable Formulations SHOMER, ISAAC
18270947 NOVEL COMPOSITION GRASER, JENNIFER E
18257699 IMPROVEMENTS IN ELECTROCHEMICAL REDUCTION OF CARBON DIOXIDE CHUNG, HOSUNG CHARLES

Top Art Units

Art UnitApps
1614 1
1612 1
1627 1
1645 1
1794 1
1682 1
1763 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18703186 Solid Compositions Comprising Tenofovir Alafenamide and/or Bictegravir DAVIS, BRIAN J 1614 §112 Non-Final OA Pending Apr 19, 2024
18696258 Injectable Formulations SHOMER, ISAAC 1612 §103 Non-Final OA Pending Mar 27, 2024
18272697 AZAQUINAZOLINE DERIVATIVES FOR USE IN TREATING OR PREVENTING DIROFILARIA INFECTION IN A MAMMAL RAO, PADMAJA S 1627 §103§112Other Non-Final OA 28d Pending Jul 17, 2023
18270947 NOVEL COMPOSITION GRASER, JENNIFER E 1645 §101 Final Rejection Pending Jul 05, 2023
18257699 IMPROVEMENTS IN ELECTROCHEMICAL REDUCTION OF CARBON DIOXIDE CHUNG, HOSUNG CHARLES 1794 §103 Non-Final OA Pending Jun 15, 2023
18111996 DETECTION OF BACTERIAL INFECTIONS SWITZER, JULIET CAROLINE 1682 §102§112Other Final Rejection 26d Pending Feb 21, 2023
16608065 POLYMERS DEL SOLE, JOSEPH STEVEN 1763 §102§103§112Other Final Rejection 56d Pending Oct 24, 2019

Managing The University of Liverpool's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month